Valeur20212022202320242025Total du passif28.15 M27 M27.51 M30.19 M23.88 MTotal des capitaux propres252.56 M243.2 M187 M130.13 M74.29 MTotal du passif et des capitaux propres280.71 M270.2 M214.51 M160.33 M98.17 MDette totale—————Dette nette—————
Barinthus Biotherapeutics plc - American Depositary Shares
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.